EGFR and head and neck cancer: Several clinical trials using epidermal growth factor receptor (EGFR)-targeted NIR-PIT in head and neck cancers (http://clinicaltrials.gov/ (accessed on 28 September 2023) Identifier: NCT02422979) are underway.